Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spansules Pharmatech is a specialized pharmaceutical company based in Hyderabad, India, that focuses on the development and manufacture of high-quality pellets and granules. The company is a leader in drug delivery systems, particularly in the production of sustained-release, delayed-release, and enteric-coated formulations. Their product portfolio includes a wide range of active pharmaceutical ingredients (APIs) in pellet form, such as omeprazole, lansoprazole, and itraconazole, which are supplied to pharmaceutical companies worldwide. Operating from GMP-compliant facilities, Spansules Pharmatech provides critical intermediates that enable the production of effective and stable oral dosage forms. The company serves as a strategic partner for global pharmaceutical manufacturers looking for reliable pelletization and granulation services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spansules Pharmatech.